Clairity BREAST receives FDA authorization for AI-based breast cancer risk prediction

[News]

Clairity, Inc., a digital health innovator advancing AI-driven healthcare solutions, has received U.S. Food and Drug Administration (FDA) De Novo authorization for CLAIRITY BREAST, a novel, image-based prognostic platform designed to predict five-year breast cancer risk from a routine screening mammogram.

More... (https://www.news-medical.net/news/20250603/Clairity-BREAST-receives-FDA-authorization-for-AI-based-breast-cancer-risk-prediction.aspx)